Suicidal Behavior clinical trials

Explore recruiting suicidal behavior clinical trials.

Recruiting suicidal behavior studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Suicidal Behavior trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2a, Multi-Center, Randomized, Parallel Group, Double Blind and Placebo-controlled Clinical Trial to Assess Safety and Tolerability as well as Explorative Efficacy of the Orthosteric Selective Muscarinic M1 Agonist NSC001 in Mild to Moderate Alzheimer’s Disease

Austria, Germany, Italy, Czechia

Therapeutic exploratory (Phase II) EU CTIS Study details

A phase II trial of belimumab in combination with rituximab/venetoclax in patients with refractory or relapsed chronic lymphocytic leukemia

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A multicenter, international, open-label, safety study of ND0612, a solution of levodopa/carbidopa delivered via a pump system as a continuous subcutaneous infusion in subjects with advanced Parkinson's Disease (BeyoND)

Italy, Austria, France, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase 2/3, Multistage, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel Group Withdrawal Study to Evaluate the Efficacy and Safety of Nipocalimab Administered to Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Italy, Greece, Czechia, Poland, Germany, France +2 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Suicidal Behavior trials by city

Suicidal Behavior in Toronto Suicidal Behavior in Vancouver Suicidal Behavior in Montreal Suicidal Behavior in Calgary Suicidal Behavior in Edmonton Suicidal Behavior in Ottawa Suicidal Behavior in Winnipeg Suicidal Behavior in Quebec City Suicidal Behavior in Hamilton Suicidal Behavior in Kitchener Suicidal Behavior in London Suicidal Behavior in Halifax Suicidal Behavior in New York Suicidal Behavior in Los Angeles Suicidal Behavior in Chicago Suicidal Behavior in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease